Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1090 | 999 | 1123 | 1385 | 1266 | 1785 |
| Fund Return | 9.04% | -0.09% | 12.33% | 11.46% | 4.83% | 5.96% |
| Place in category | 1022 | 1296 | 969 | 889 | 850 | 410 |
| % in Category | 53 | 70 | 54 | 58 | 67 | 56 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| BE6366529319 | 3.96B | 4.80 | - | - | ||
| Belfius Pension Fund High Equities | 2.58B | 5.96 | 9.11 | 5.19 | ||
| Belfius Innovative Technology C | 2.06B | 38.63 | 24.82 | - | ||
| Belfius Pension Fund Balanced Plus | 1.42B | 0.81 | 6.35 | 3.57 | ||
| BE6314674712 | 589.99M | 10.47 | 6.78 | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| DPAM HORIZON B Active Strategy A | 294.83M | 8.10 | 9.82 | 6.21 | ||
| DPAM HORIZON B Active Strategy B | 294.83M | 8.10 | 9.82 | 6.21 | ||
| BE6217862653 | 203.81M | 11.73 | 13.38 | 7.12 | ||
| Nagelmackers MultiFund Growth | 97.11M | 8.53 | 10.30 | 5.29 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Cleome Index USA Equities ZB USD Acc | LU3199977763 | 19.52 | - | - | |
| Cleome Index Europe Equities ZB EUR Inc | LU3199978068 | 14.46 | - | - | |
| Candriam Sustainable Eq US ZB USD Acc | LU3175972408 | 13.96 | - | - | |
| Candriam Sst Eq Em Mrkts ZB € Acc | LU3175971343 | 5.31 | - | - | |
| Candriam Bds Euro Dvrs ZB CAP EUR Acc | LU3168152943 | 4.59 | - | - |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Sell |
| Technical Indicators | Sell | BUY | Sell |
| Summary | Sell | Neutral | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review